S

Sofwave Medical Ltd
TASE:SOFW

Watchlist Manager
Sofwave Medical Ltd
TASE:SOFW
Watchlist
Price: 2 855 ILS 0.18% Market Closed
Market Cap: 975.1m ILS

ROE
Return on Equity

2.6%
Current
-22%
Average
3.3%
Industry

ROE, or Return on Equity, is a key financial ratio that measures a company's profitability. Specifically, it measures how many dollars of profit are generated for each dollar of shareholder's equity. A higher ROE indicates better financial performance and effective use of capital, making it a valuable metric for investors assessing a company's earning potential.

ROE
2.6%
=
Net Income
684k
/
Equity
26.1m

ROE Across Competitors

No Stocks Found

Sofwave Medical Ltd
Glance View

Market Cap
975.1m ILS
Industry
Health Care

Sofwave Medical Ltd. engages in development, production, marketing, maintenance, and distribution of medical technology for firming and rejuvenating facial and neck skin. The firm operates itself and through its subsidiaries in the field of development, production, marketing, support and distribution of medical technology Sofwave that delivers Synchronous Ultrasound Parallel Beam SUPERB technology for skin tightening and rejuvenation treatments for the face and neck, which provides a non-invasive solution for skin rejuvenation and tightening, in a safe and clinically effective manner. In addition, the group provides services technical and clinical support for the product it provides. The firm has subsidiary in United States -Sofwave Medical Inc.

SOFW Intrinsic Value
HIDDEN
Show
What is Return on Equity?

ROE, or Return on Equity, is a key financial ratio that measures a company's profitability. Specifically, it measures how many dollars of profit are generated for each dollar of shareholder's equity. A higher ROE indicates better financial performance and effective use of capital, making it a valuable metric for investors assessing a company's earning potential.

ROE
2.6%
=
Net Income
684k
/
Equity
26.1m
What is the ROE of Sofwave Medical Ltd?

Based on Sofwave Medical Ltd's most recent financial statements, the company has ROE of 2.6%.

Back to Top